Skip to content

Opioid Free Anaesthesia In Patients Undergoing Surgery For Pancreatic Cancer

Opioid Free Anaesthesia In Pancreatico-Duodenectomy- Single Centre Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070339
Enrollment
35
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C250- Malignant neoplasm of head of pancreas

Interventions

Intervention1: nil: nil Intervention2: opioid free anesthesia technique: Epidural catheter will be placed at T6-T8 level,Test dose will be given ( 3ml , 2 percent xylo-adr ) , if negative 12 ml bolus

Sponsors

Basavatarakam Indo American Cancer hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA status from 1to 3 2. Surgery whipples procedure

Exclusion criteria

Exclusion criteria: 1. ASA 4 2. Local anaesthetic allergy 3. Infection at injection site 4. Coagulopathy 5. Critical coronary artery disease 6. Renal dysfunction 7. Hepatic dysfunction ( CTP SCORE of C)

Design outcomes

Primary

MeasureTime frame
1.To assess the no of patients requiring rescue opioid medications and the amount of opioid required in intravenous fentanyl equivalentTimepoint: 0 min, 30 mins , 60 mins, 90 mins , 120 mins , 4th hr , 6th hr , 8th hr, 12th hr, 24th hr , 28th hr, 32th hr, 36th hr, 40th hr, 44th hr, 48th hr, 52th hr, 56th hr, 60th hr, 64th hr, 68th hr, 72th hr

Secondary

MeasureTime frame
1. To assess changes in intraoperative hemodynamics i.e., before and after skin incision. 2. To assess the incidence post extubation post operative complication according to Clavein-Dindo classification 3. To assess the incidence of length of hospital stay and 30 day mortality Timepoint: before and after skin incision 30, 60, 90, 120 mins 3rd, 4th, 5th, 6th, 7th, 8th, 9th , 10th, 11th, 12th, 13th hr

Countries

India

Contacts

Public ContactTaseen Mahvish

Basavatarakam Indo American Cancer Hospital And Research Institute

taseen.mahvish@gmail.com9703372660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026